Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)
This partially randomized phase II/III trial studies how well cisplatin and combination
chemotherapy works in treating children and young adults with hepatoblastoma or liver cancer
after surgery. Drugs used in chemotherapy, such as cisplatin, doxorubicin, fluorouracil,
vincristine sulfate, carboplatin, etoposide, irinotecan, sorafenib, gemcitabine and
oxaliplatin, work in different ways to stop the growth of tumor cells, either by killing the
cells, by stopping them from dividing, or by stopping them from spreading. Giving combination
chemotherapy after surgery may kill more tumor cells.
View more details from ClinicalTrials.gov.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.